Wave Life Sciences Ownership | Who Owns Wave Life Sciences?
Wave Life Sciences Ownership Summary
Wave Life Sciences is owned by 89.61% institutional investors, 15.04% insiders. Ra capital management is the largest institutional shareholder, holding 14.05% of WVE shares. BB Biotech AG Ord is the top mutual fund, with 2.69% of its assets in Wave Life Sciences shares.
WVE Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | Wave Life Sciences | 89.61% | 15.04% | -4.65% |
Sector | Healthcare Stocks | 87.31% | 8.86% | 3.83% |
Industry | Biotech Stocks | 108.49% | 8.78% | -17.27% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
Holder | Shares | % Holding | Value |
---|---|---|---|
Ra capital management | 18.20M | 14.05% | $90.83M |
Maverick capital | 7.67M | 5.92% | $38.27M |
Blackrock | 6.74M | 5.21% | $33.63M |
M28 capital management lp | 6.16M | 4.76% | $30.76M |
Adage capital partners gp | 5.36M | 4.14% | $26.74M |
683 capital management | 5.33M | 4.11% | $26.57M |
Artal group | 4.57M | 3.53% | $22.79M |
Bellevue group | 4.09M | 3.16% | $20.43M |
Kynam capital management, lp | 3.98M | 3.07% | $19.84M |
Primecap management co/ca/ | 2.66M | 2.06% | $13.29M |
Top Institutional Shareholders by % of Total Assets
Holder | Shares | % Assets | Value |
---|---|---|---|
M28 capital management lp | 6.16M | 39.88% | $30.76M |
683 capital management | 5.33M | 2.01% | $26.57M |
Kynam capital management, lp | 3.98M | 1.53% | $19.84M |
Ra capital management | 18.20M | 1.20% | $90.83M |
Maverick capital | 7.67M | 0.73% | $38.27M |
Silverarc capital management | 495.47K | 0.58% | $2.47M |
Artal group | 4.57M | 0.58% | $22.79M |
Emerald advisers | 2.49M | 0.52% | $12.44M |
Ikarian capital | 575.09K | 0.50% | $2.87M |
Emerald mutual fund advisers trust | 1.82M | 0.48% | $9.09M |
Top Buyers
Holder | Shares | % Assets | Change |
---|---|---|---|
Emerald advisers | 2.49M | 0.52% | 2.49M |
Emerald mutual fund advisers trust | 1.82M | 0.48% | 1.82M |
State street | 2.26M | 0.00% | 749.01K |
Vanguard group | 2.42M | 0.00% | 583.60K |
Artal group | 4.57M | 0.58% | 514.85K |
Top Sellers
Holder | Shares | % Assets | Change |
---|---|---|---|
Point72 asset management | 115.48K | 0.00% | -1.86M |
Woodline partners lp | - | - | -948.44K |
M28 capital management lp | 6.16M | 39.88% | -835.45K |
Fmr | 561.08K | 0.00% | -607.69K |
Laurion capital management lp | - | - | -516.47K |
New Positions
Holder | Shares | % Assets | Change | Value |
---|---|---|---|---|
Emerald advisers | 2.49M | 0.52% | 2.49M | $12.44M |
Emerald mutual fund advisers trust | 1.82M | 0.48% | 1.82M | $9.09M |
Moody aldrich partners | 179.36K | 0.17% | 179.36K | $895.00K |
Y-intercept (hong kong) | 68.80K | 0.02% | 68.80K | $343.33K |
Janus henderson group | 51.70K | 0.00% | 51.70K | $256.95K |
Sold Out
Holder | Change |
---|---|
Allworth financial lp | -3.00 |
Nelson, van denburg & campbell wealth management group | -12.00 |
Aspire private capital | -150.00 |
Federated hermes | -493.00 |
Hillsdale investment management | -1.10K |
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Sep 30, 2024 | 163 | 10.88% | 118,791,972 | 26.74% | 89 | 1.71% | 95 | 15.85% | 39 | -15.22% |
Jun 30, 2024 | 147 | 9.70% | 93,731,224 | 2.54% | 72 | 1.45% | 82 | -6.82% | 46 | 43.75% |
Mar 31, 2024 | 134 | 13.56% | 91,412,722 | 0.25% | 70 | 1.02% | 88 | 2.33% | 32 | 190.91% |
Dec 31, 2023 | 118 | 35.63% | 91,181,370 | 25.54% | 83 | 1.77% | 86 | 120.51% | 11 | -60.71% |
Sep 30, 2023 | 87 | 3.57% | 72,629,619 | 0.64% | 68 | 1.46% | 39 | -17.02% | 28 | 47.37% |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
BB Biotech AG Ord | 4.09M | 2.69% | - |
PRIMECAP Odyssey Aggressive Growth | 2.52M | 1.66% | -67.37K |
iShares Russell 2000 ETF | 2.47M | 1.62% | -9.47K |
T. Rowe Price Health Sciences | 2.02M | 1.32% | 518.02K |
Vanguard Institutional Extnd Mkt Idx Tr | 1.71M | 1.12% | 8.78K |
T. Rowe Price New Horizons | 1.64M | 1.07% | 834.93K |
Artisan Non-U.S. Small-Mid Growth Comp | 1.27M | 0.84% | 1.27M |
Artisan International Small-Mid Investor | 1.27M | 0.84% | 1.27M |
Polar Capital Biotech S Inc | 1.00M | 0.66% | - |
Loomis Sayles Small Cap Growth Instl | 970.49K | 0.64% | 970.49K |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
Nov 25, 2024 | BOLNO PAUL | President and CEO | Sell | $750.00K |
Nov 15, 2024 | BOLNO PAUL | President and CEO | Sell | $733.67K |
Nov 08, 2024 | Francis Chris | See Remarks | Sell | $576.00K |
Oct 16, 2024 | Francis Chris | See Remarks | Sell | $902.34K |
Oct 16, 2024 | Francis Chris | See Remarks | Sell | $1.12M |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2024 Q4 | - | 8 |
2024 Q3 | 1 | 2 |
2024 Q2 | - | 1 |
2024 Q1 | - | - |
2023 Q4 | 3 | - |
WVE Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools